Diacylglycerol kinase α‐selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines
Diacylglycerol kinase α‐selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines
复制标题
二酰甘油激酶 α 选择性抑制剂诱导细胞凋亡并降低黑色素瘤和其他几种癌细胞系的活力
DOI:
10.1002/jcb.28288
复制
发表时间:
2018
影响因子:
4
通讯作者:
Sakane Fumio
中科院分区:
文献类型:
--
作者:
Yamaki Atsumi;Akiyama Rino;Murakami Chiaki;Takao Saki;Murakami Yuki;Mizuno Satoru;Takahashi Daisuke;Kado Sayaka;Taketomi Akinobu;Shirai Yasuhito;Goto Kaoru;Sakane Fumio
Diacylglycerol (DG) kinase (DGK), which phosphorylates DG to generate phosphatidic acid (PA), consists of ten isozymes (α–к). Recently, we identified a novel small molecule inhibitor, CU‐3, that selectively inhibits the activity of the α isozyme. In addition, we newly obtained Compound A, which selectively and strongly inhibits type I DGKs (α, β, and γ). In the present study, we demonstrated that both CU‐3 and Compound A induced apoptosis (caspase 3/7 activity and DNA fragmentation) and viability reduction of AKI melanoma cells. Liquid chromatography‐mass spectrometry revealed that the production of 32:0‐ and 34:0‐PA species was commonly attenuated by CU‐3 and Compound A, suggesting that lower levels of these PA molecular species are involved in the apoptosis induction and viability reduction of AKI cells. We determined the effects of the DGKα inhibitors on several other cancer cell lines derived from refractory cancers. In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. Interestingly, Western blot analysis indicated that the DGKα expression levels were positively correlated with the sensitivity to the DGK inhibitors. Because both CU‐3 and Compound A induced interleukin‐2 production by T cells, it is believed that these two compounds can enhance cancer immunity. Taken together, our results suggest that DGKα inhibitors are promising anticancer drugs.
登录
查看更多内容
DOI:
10.1073/pnas.90.16.7598
发表时间:
1993-08-15
影响因子:
11.1
作者:
GOTO, K;KONDO, H
通讯作者:
KONDO, H
影响因子:
4.4
作者:
Prinz, Petra U.;Mendler, Anna N.;Noessner, Elfriede
通讯作者:
Noessner, Elfriede
影响因子:
64.8
作者:
SAKANE, F;YAMADA, K;TANABE, T
通讯作者:
TANABE, T
DOI:
--
发表时间:
2007
期刊:
Biochim.Biophys.Acta-Mol.Cell Biol.Lipids 1771
影响因子:
--
作者:
Yanagisawa;K.;et. al.
通讯作者:
et. al.
DOI:
--
发表时间:
--
期刊:
影响因子:
--
作者:
通讯作者:
--